Targeting protein prenylation for cancer therapy

Berndt, Norbert, Hamilton, Andrew D., Sebti, Saïd M.·2011·Nature Reviews Cancer
DOI 10.1038/nrc3151

Cited by (622)

Items 501–600 of 622

  1. HIGH DOSE SIMVASTATIN AS A POTENTIAL ANTICANCER THERAPY IN LEUKEMIA PATIENTS
    Tamer A. Ahmed · 2013 · UKnowledge (University of Kentucky)
  2. Geranylgeranyltransferase-1 Inhibitors
    Norbert Berndt, Andrew D. Hamilton, Saı̈d M. Sebti · 2011 · The Enzymes
  3. Extracellular Signal-Regulated Kinase (ERK1 and ERK2) Inhibitors
    Ahmed A. Samatar · 2016 · Elsevier eBooks
  4. Graphical Learning and Causal Inference for Drug Repurposing
    Tao Xu, Jinying Zhao, Momiao Xiong · 2023 · medRxiv
  5. Biochemical Pathways in Cancer
    Eun-Kyoung Yim Breuer, Mandi M. Murph, Rolf J. Craven · 2012 · Biochemistry Research International
  6. Chemical proteomic approaches to investigate S-prenylation
    Sarah Hassan, James Zhang, Wouter W. Kallemeijn, Edward W. Tate · 2025 · Methods in enzymology on CD-ROM/Methods in enzymology
  7. Uncovering protein prenylation in Th1 cells: novel prenylation sites and insights into statin and farnesyltransferase inhibition
    Jana Koch, Alessandra Ruggia, Carina Beha, Irina Wipf, Damir Zhakparov, Patrick Westermann, Svenja Schmelzer, Anja Heider, Klemens Fröhlich, Katja Baerenfaller · 2025 · BMC Biology
  8. Inositol (1,4,5)-trisphosphate 5-phosphatase promotes survival of uveal melanoma by regulating oncogenic G protein–driven calcium oscillations
    Michael D. Onken, Carol M. Makepeace, Kevin M. Kaltenbronn, McKenzie Demourelle-Washington, Kisha Piggott, D. Goldfarb, D. Kast, Silvia Jansen, Kendall J. Blumer · 2025 · Journal of Biological Chemistry
  9. Geranylgeranyl transferase‐1 inhibitor GGTI ‐2417 enhances the anti‐tumour efficacy of histone deacetylase inhibitors in different T‐cell lymphoma lines
    Xiaoyan Hu, Lin Li, Jewel Nkwocha, Hitesh Vasiyani, Aslamuzzaman Kazi, Saı̈d M. Sebti, Steven Grant · 2025 · British Journal of Haematology
  10. Oleate activates PLD2 lipase and GEF activity by modulating membrane microdomain dynamics via S-acylation
    Zhiqiang Guo, Karl‐F. Bergeron, Cathérine Mounier · 2025 · Journal of Lipid Research
  11. FGTI-2734 prevents ERK-mediated resistance and enhances MRTX1133 efficacy in KRAS G12D pancreatic cancer
    Deblina Ghosh, Aslamuzzaman Kazi, Hitesh Kumar Kantilal Vasiyani, Vignesh Vudatha, Nicolas Lecomte, Christine A. Iacobuzio–Donahue, Jose Trevino, Said M. Sebti · 2026 · European Journal of Cancer
  12. The Spatial Organization of Ras Signaling
    Bjoern Papke, Malte Schmick, Nachiket Vartak, Philippe I. H. Bastiaens · 2014 · Springer eBooks
  13. Plant Compounds Acting on the Cytoskeleton
    Einat Sadot · 2013 · Plant cell monographs
  14. Mutational Activation of KRAS and BRAF in Colorectal Cancer
    Katherine H. Pedone, Jennifer L. Sells, Channing J. Der · 2013 · Springer eBooks
  15. SYNFORM ISSUE 2013/9
    Matteo Zanda · 2013 · Synthesis
  16. Pathology and Molecular Pathology of Pancreatic Cancer
    Wai Chin Foo, Huamin Wang · 2016 · Springer eBooks
  17. Mevalonate Pathway-mediated ER Homeostasis Is Required for Haploid Stability in Human Somatic Cells
    Kan Yaguchi, Kimino Sato, Koya Yoshizawa, Daisuke Mikami, Kohei Yuyama, Yasuyuki Igarashi, Gábor Bánhegyi, Éva Margittai, Ryota Uehara · 2020 · Cell Structure and Function
  18. Oral Cancer Immunotherapy through a Simvastatin‐Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity
    Seong A Kim, Gi‐Hoon Nam, Young Rang Bae, Saurav Kumar Jha, Seohyun Kim, Yoonjeong Choi, Yeji Lee, Minsu Kwon, Cheolhyun Jeong, Youngro Byun et al. · 2021 · Advanced Therapeutics
  19. Development of PD3 and PD3-B for PDEδ inhibition to modulate KRAS activity
    Jungeun Lee, Ho Jin Lee, Yeongcheol Lee, Bumhee Lim, Jongsik Gam, Dong‐Chan Oh, Jeeyeon Lee · 2022 · Journal of Enzyme Inhibition and Medicinal Chemistry
  20. Research status and hotspots on the mechanisms of liver X receptor in cancer progression: A bibliometric analysis
    Y. Ann Chen, Siqi Deng, Jiexia Xu, Yan Yu, Shuwen Lan, Mingzhang Guo · 2024 · Medicine
  21. Search for Inhibitors of Ras-Driven Cancers
    Adam B. Keeton, Gary Anthony Piazza · 2016 · Elsevier eBooks
  22. Cloning and Sequence Analysis of an Acetyl-CoA C-Acetyltransferase Gene (AACT) from Chamaemelum nobile
    Mingyue Fu, Xiaomeng Liu, Xiangxiang Meng, Lanlan Wang, Junping Tan, Xian Zhou, Feng Xu · 2017 · International Journal of Current Research in Biosciences and Plant Biology
  23. Delta Hepatitis – 2019. Part II: Modern Treatment and Its Promise
    Boleslav N. Levitan, Дедов Алексей Владимирович · 2019 · Effective Pharmacotherapy
  24. Regulation of the Tumor Suppresser p53 and Survivin by Ras and Ral GTPases:Implications for Malignant Transformation
    Awet Tecleab · 2013 · Digital Commons - University of South Florida (University of South Florida)
  25. SYNFORM ISSUE 2013/09
    Matteo Zanda · 2013 · Synfacts
  26. Targeting the Ras-Ral effector pathway for cancer treatment
    Leanna R. Gentry · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  27. Geranylgeranylated-SCF FBXO10 Regulates Selective Outer Mitochondrial Membrane Proteostasis and Function
    Sameer Ahmed Bhat, Zahra Vasi, Liping Jiang, Shruthi Selvaraj, Rachel Ferguson, Anish Gudur, Hagar Ismail, Ritika Adhikari, Avantika Dhabaria, Beatrix M. Ueberheide et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Uncovering Protein Prenylation in Th1 Cells: Novel Prenylation Sites and Insights into Statin and Farnesyltransferase Inhibition
    Jana Koch, Alessandra Ruggia, Carina Beha, Irina Wipf, Damir Zhakparov, Patrick Westermann, Svenja Schmelzer, Anja Heider, Klemens Fröhlich, Katja Baerenfaller · 2025 · Research Square
  29. RAS Genes and Cancer
    Tikvah K. Hayes, Jeran K. Stratford, Andrea Wang‐Gillam, Channing J. Der · 2014 · Springer eBooks
  30. Using GEMMs to investigate novel therapeutic strategies for colorectal cancer
    Meera Raja · 2013 · ORCA Online Research @Cardiff (Cardiff University)
  31. Estudio del mecanismo de acción en la interacción entre estatinas y monoterpenos en animales inmunodeficientes portadores y no portadores de tumores de origen humano
    Marianela Galle · 2013
  32. Protein S-glutathionylation: new insights on pre-oncogenic cellular model and formulation of a new molecular mechanism
    Luisa Ercolani · 2013 · Università Politecnica delle Marche (Università Politecnica delle Marche)
  33. SIGNALING MECHANISMS IN SEPSIS-INDUCED IMMUNE DYSFUNCTION
    Zirak Hasan · 2013 · Lund University Publications (Lund University)
  34. Correction: Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins
    Arafath Kaja Najumudeen, Monika Köhnke, Maja Å olman, Kirill A. Alexandrov, Daniel Abankwa · 2014 · PLoS ONE
  35. Hitting cancer where it hurts most
    Hendrik J. Kuiken · 2012 · Utrecht University Repository (Utrecht University)
  36. Light and pH dual responsive polyion complex micelles for efficient protein delivery
    Qiao Jin, Tongjiang Cai, Jian Ji · 2015 · Journal of Controlled Release
  37. The Ras effector NORE1A forms a tumor suppressor complex with BRCA1.
    Nicholas C Nelson · 2015
  38. recruitment in septic lung injury formation in alveolar macrophages and neutrophil Geranylgeranyl transferase regulates CXC chemokine
    Zirak Hasan, Karzan Palani, Ingvar Syk, Bengt W. Jeppsson · 2016
  39. MEK inhibition in pancreas cancer
    Francesca Vena · 2016 · UCL Discovery (University College London)
  40. MicroRNAs and epigenetics in chemical carcinogenesis : an integrative toxicogenomics-based approach
    Linda Rieswijk · 2016
  41. Identifying Novel Inhibitors of Epithelial to Mesenchymal Transition (EMT) for Targeting Pancreatic Cancer Metastasis and Cancer Stem Cells
    Kishore Polireddy · 2015 · KU ScholarWorks (The University of Kansas)
  42. Investigação das quinases Aurora A e Aurora B na tumorigenicidade mediada pelo oncogene KRAS
    Edmilson Ozorio dos Santos · 2017 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  43. Estudio del mecanismo de acción de distintos quimiotipos de Lippia alba sobre el metabolismo lipídico y la proliferación celular
    Montero Villegas, Sandra · 2017
  44. Pravastatin: A First Generation HMG CoA Reductase Inhibitor ☆
    Jerry W. Reagan · 2018 · Elsevier eBooks
  45. Statins and Protein Prenylation in the Retina
    Jennifer Y. M. Ling · 2017 · ERA: Education and Research Archive (University of Alberta)
  46. Regulation of lysophosphatidate-induced mechanisms of chemo-resistance
    Ganesh Venkatraman · 2015 · ERA: Education and Research Archive (University of Alberta)
  47. Elucidating the Mechanisms of Apoptosis Induced by a Novel Geranylgeranyl Diphosphate Synthase Inhibitor in T-cell Acute Lymphoblastic Leukemia
    Sherry S. Agabiti · 2018 · OpenCommons at University of Connecticut (University of Connecticut)
  48. Blocking KRAS Signaling for the Treatment of Lung Cancer: Mission Possible?
    Yoshitsugu Horio · 2018 · Haigan
  49. Explorando a quinase IKK como um alvo terapêutico para células iniciadoras de tumor pulmonares induzidas pelo oncogene KRAS
    Felipe Silva Rodrigues · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  50. Evaluación de potenciales propiedades antiaterogénicas y antitumorales del aceite de la cáscara de Citrus reticulata
    María Agustina Castro · 2019
  51. [Effects of geranylgeranyltransferaseⅠsilencing on the proliferation of tongue squamous cancer cells].
    Ying Wang, Wang Qimin, LI Jing-hua, Han Jinhong, Wang Lili, Chao Chen, Zhou Jianhua, Lei Tong, Lu Xufei, Zhou Yuan et al. · 2017 · PubMed Central
  52. Urinary Volatile Organic Compounds for Detection of Breast Cancer and Monitoring Chemical and Mechanical Cancer Treatments in Mice
    Meghana Teli · 2019 · Purdue e-Pubs (Purdue University System)
  53. Regulation of the kRAS Promoter in Pancreatic Cancer by Proteins and Small Molecules
    Harshul Batra · 2017 · ProQuest Demo Repository
  54. Statins, Lipids, and Mutations: Consequences for the Heart and Immune System
    Emil G. Ivarsson · 2019 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  55. Evaluating the therapeutic potential of the PAK1 and TBK1 kinases in pancreatic ductal adenocarcinoma
    Nicole M. Baker · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  56. [Effects of geranylgeranyltransferase Ⅰ gene silencing by RNA interference on the migration and invasion of tongue carcinoma].
    Chen Zhenggang, Wang Shuren, LI Jing-hua, Han Jinhong, Wang Qimin, Lei Tong, Liu Wenjun, Fang Yang, Guo Qingyuan, Guo Dawei et al. · 2017 · PubMed Central
  57. Investigating Nrf2 function in disease using enrichment analysis predictions and top-down systems biology
    Petri Pölönen · 2013 · UEF eRepo (University of Eastern Finland)
  58. Ras and Ras Signaling as a Therapeutic Target in Cancer
    Bailee H. Sliker, Paul M. Campbell · 2021 · Elsevier eBooks
  59. Chemical Approach Toward Controlling of Transient Protein Interactions
    Junko Ohkanda · 2021 · Springer eBooks
  60. Lipophilic Salirasib analogs with enhanced antiproliferative activity against human solid tumor cell lines
    Exequiel O. J. Porta, María Sol Ballari, José M. Padrón, Guillermo R. Labadié · 2021 · ChemRxiv
  61. "El soneto a Granada" de Pablo Antonio Cuadrado
    Nicasio Urbina · 2010 · Hispanic poetry review
  62. Las conclusiones de este debate serán estudiadas por la Administración
    Miguel Muñiz de las Cuevas · 1985 · Bolsa de Madrid
  63. Phosphorylation of interfacial phosphosite leads to increased binding of Rap-Raf complex
    T Devanand, Susmita Ghosh, Prasanna Venkatraman, Satyavani Vemparala · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Spiropyrrolizidine and piperazine derivatives: Synthesis and evaluation on kras expression levels in human colon cancer cells
    Victor Liu · 2019
  65. Precision Medicine in Pancreatic Cancer
    Jaymes Beech · 2015
  66. The structural basis of allosteric communication networks of Ras GTPases and their oncogenic mutants
    Alicia Yvette Volmar · 2020
  67. Data from Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity
    Feifei Xu, Zining Wang, Hongxia Zhang, Jiemin Chen, Xiaojuan Wang, Lei Cui, Chunyuan Xie, Mengyun Li, Fang Wang, Penghui Zhou et al. · 2023
  68. Supplementary Table from Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma
    Sehrish Javaid, Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon, Da'Jhnae Gambrell-Sanders, Andrew M. Waters, Kathryn N. Lambert, J. Nathaniel Diehl et al. · 2023
  69. Novel YAP1/TAZ Pathway Inhibitors Identified Through Phenotypic Screening with Potent Anti-Tumor Activity via Blockade of GGTase-I / Rho-GTPase Signaling
    Keith Graham, Philip Lienau, Benjamin Bader, Stefan Prechtl, Jan Naujoks, Ralf Lesche, Joerg Weiske, Julia Kuehnlenz, Krzysztof Brzezinka, Lisette Potze et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Proteinlerin Posttranslasyonel Modifikasyonları
    Nadir Gül · 2023 · Akademisyen Kitabevi eBooks
  71. Comprehensive analysis of CXXX sequence space reveals that S. cerevisiae GGTase-I mainly relies on a 2 X substrate determinants
    Anushka Sarkar, Emily R. Hildebrandt, Khushi V. Patel, Emily T. Mai, Sumil S. Shah, June H Kim, Walter K. Schmidt · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Additional file 5 of Disruption of protein geranylgeranylation in the cerebellum causes cerebellar hypoplasia and ataxia via blocking granule cell progenitor proliferation
    Cheng, Qi, Jing Wu, Yingqian Xia, Cheng, Qing, Yinjuan Zhao, Peixiang Zhu, Wangling Zhang, Shihu Zhang, Lei Zhang, Yushan Yuan et al. · 2023 · Figshare
  73. Upstream Proteolysis by Ste24 does not Require a C-Terminal Methyl Ester as Revealed Using 33-Residue a-Factor Precursor Peptide Substrates Synthesized via Epimerization-Free Methods
    Taysir K. Bader, Shanica M. Brown, Christine A. Hrycyna, Mark Dewey Distefano · 2025 · International Journal of Peptide Research and Therapeutics
  74. Targeting RAS and associated proteins
    Matthias Philipp Müller, Roger Sidney Goody, Daniel Rauh · 2025 · Elsevier eBooks
  75. Harnessing proteomics for precision medicine in lung cancer
    Olena Berkovska · 2025
  76. GGPS1 Gene Expression in Triple-Negative Breast Cancer: Impact on the Risk of Distant Metastasis and Potential Use as a Target for Therapy
    Danila Coradini · 2025 · Archives of Oncology and Cancer Therapy
  77. Comprehensive analysis of a real‐world cohort identifies geranylgeranyl diphosphate synthase 1 as a predictor of chemoresistance in small cell lung cancer
    Yi Deng, Chenchen Guo, Tengfei Zhang, Yuan Chen, Xin Zhang, Hongbin Ji, Liang Hu · 2025 · International Journal of Cancer
  78. Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer
    Alica K. Beutel, Sabrina E. Calderon, Ethan Nghiem, Kevin Christian Montecillo Gulay, Leonor Patricia Schubert Santana, Eleni Zimmer, Rima Singh, Cecily Anaraki, Natalie Yousefian, Chantal Allgöwer et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  79. IL-33-mediated mast cell and eosinophil function requires isoprenylation
    Jason R. Burchett, Aditya Kotha, Destiny T. Davis, Kaitlyn G. Jackson, Jordan M. Dailey, Tania D. Maldonado, Tamara T. Haque, Zakaria Y. Hussain, John M. Ching, Pamela A. Frischmeyer‐Guerrerio et al. · 2025 · Frontiers in Immunology
  80. Biodegradable polycarbonate-based stimuli-responsive nanosystems for intracellular delivery
    Wei Chen · 2013
  81. Additional file 2 of Disruption of protein geranylgeranylation in the cerebellum causes cerebellar hypoplasia and ataxia via blocking granule cell progenitor proliferation
    Cheng, Qi, Wu, Jing, Yingqian Xia, Cheng, Qing, Zhao, Yinjuan, Peixiang Zhu, Wangling Zhang, Zhang, Shihu, Zhang, Lei, Yushan Yuan et al. · 2023 · Figshare
  82. Additional file 4 of Disruption of protein geranylgeranylation in the cerebellum causes cerebellar hypoplasia and ataxia via blocking granule cell progenitor proliferation
    Cheng, Qi, Wu, Jing, Yingqian Xia, Cheng, Qing, Zhao, Yinjuan, Peixiang Zhu, Wangling Zhang, Zhang, Shihu, Zhang, Lei, Yushan Yuan et al. · 2023 · Figshare
  83. Additional file 3 of Disruption of protein geranylgeranylation in the cerebellum causes cerebellar hypoplasia and ataxia via blocking granule cell progenitor proliferation
    Cheng, Qi, Wu, Jing, Yingqian Xia, Cheng, Qing, Zhao, Yinjuan, Peixiang Zhu, Wangling Zhang, Zhang, Shihu, Zhang, Lei, Yushan Yuan et al. · 2023 · Figshare
  84. Additional file 1 of Disruption of protein geranylgeranylation in the cerebellum causes cerebellar hypoplasia and ataxia via blocking granule cell progenitor proliferation
    Cheng, Qi, Wu, Jing, Yingqian Xia, Cheng, Qing, Zhao, Yinjuan, Peixiang Zhu, Wangling Zhang, Zhang, Shihu, Zhang, Lei, Yushan Yuan et al. · 2023 · Figshare
  85. Additional file 1 of How cancer cells remodel lipid metabolism: strategies targeting transcription factors
    Jeong, Do-Won, Seulbee Lee, Chun, Yang-Sook · 2021 · Figshare
  86. KRAS Can Bind to FTase Despite Disruption of the CAAX Binding Site
    Martin Carion, Rebeca Cuesta, Dominika Kowalczyk, Wim J. Smets, Erik Soons, Hugo Klaassen, Bart Vanderhoydonck, Arnaud Marchand, Matthias Versele, Patrick Chaltin et al. · 2026 · Biochemistry
  87. Squalene synthase induces ERα expression via cholesterol supplementation to confer statin resistance in lung cancer cells
    Yi‐Fang Yang, Yu-Chan Chang, Ming‐Hsien Chan, Min-Hsi Lin, Chih-Jen Yang, Ming-Shyan Huang, Yi‐Hua Jan, Michael Hsiao · 2026 · Cancer Cell International
  88. Medulloblastoma response to mevalonate pathway inhibition is independent of p53 status
    Charley Comer, Christopher Edwards, Sabrina Caporali, Yuhui Lu, Alessio Butera, David Michod, Andreas J Gruber, Ivano Amelio, Maria Victoria Niklison-Chirou · 2026 · Biology Direct
  89. Caractérisation des voies de signalisation des oncogènes FGFR3 muté et FGFR3-TACC3 dans les carcinomes de vessie
    M. Mahé · 2015
  90. Régulation de l'expression de ligands de l'immunité par la voie Rho/ROCK sur les mélanomes
    Lotefa Teiti · 2015
  91. Vers la vectorisation des bisphophonates par les peptides de pénétration cellulaire
    Nicolas Guedeney · 2018
  92. Liver pathophysiology at the single cell level : characterization of cellular heterogeneity and identification of novel therapeutic targets for chronic liver diseases and hepatocellular carcinoma
    Antonio Saviano · 2019 · theses.fr (ABES)
  93. NMR structural studies of G-quadruplexes nucleic acids from KRAS and their interaction with ligands.
    Julien Marquevielle · 2019
  94. Approches "perte de fonction" pour l'étude des interactions hôte-virus dans le cas des hépatites virales chroniques
    Vincent Turon‐Lagot · 2020 · theses.fr (ABES)
  95. Exploring PI3K signalling dynamics in pancreatic cancer
    Carmen Fernanda Ramos Delgado · 2020 · theses.fr (ABES)
  96. Metabolic homeostasis and regulatory mechanisms of cellular senescence : roles of ITPR2-mediated calcium fluxes and mevalonate pathway
    Dorian V. Ziegler · 2020
  97. Compréhension des étapes précoces de la résistance adaptative aux inhibiteurs de tyrosine kinase de l'EGFR dans les cancers bronchiques
    Sarah Figarol · 2020 · theses.fr (ABES)
  98. Nouvelles stratégies thérapeutiques dans le traitement du gliome infiltrant du tronc cérébral
    Guillaume Herrault · 2024
  99. Protein lipidation in cardiovascular homeostasis, development, and disease
    David Cully, Shenice Harrison, Matheus Sadovsky, Gregory E. Miner, W. Daniel Edwards · 2026 · Clinical Science
  100. Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase 1 Inhibitors for Targeting Mevalonate Metabolism in Cancer
    Liang Sun, Sang Ah Yi, Brittany Q Pham, Antoine Mocellin, Sagnik Sen, M. Jason de la Cruz, Alban Ordureau, Heeseon An · 2026 · Journal of the American Chemical Society